Bluechiip (ASX:BCT) share price explodes 63% on Fujifilm deal

The company is planning for a big 24 months ahead…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bluechiip Ltd (ASX: BCT) share price is rocketing to a 3-month high today. This comes after the company announced a lucrative contract with California-based Fujifilm Irvine Scientific, Inc. (FISI).

At the time of writing, Bluechiip shares are surging 63.33% higher to 4.9 cents apiece.

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

Bluechiip signals strong growth opportunity ahead

Bluechiip develops temperature and tracking solutions for biosamples in the health and life sciences industries. Today, investors are driving up the Bluechiip share price following the company's latest news to the ASX.

In its statement, Bluechiip advised it has signed a two-year licence and development agreement with FISI.

Founded in 1970, FISI is the world's leading manufacturer of cell culture media, reagents, and medical devices. These products are used across cell therapy, regenerative medicine, assisted reproductive technology (ART), and industrial cell culture markets.

Under the agreement, FISI will pay Bluechiip to customise and develop a range of technologies for the ART (also known as in-vitro fertilisation, or IVF) market segment. The goal is to improve the traceability of samples and simplify workflows for FISI.

During this initial licence and development period, the companies will work together to agree on a supply agreement for the sale and distribution of the customised Bluechiip products including minimum volumes, pricing, and detailed commercial terms.

Commenting on the news fuelling the Bluechiip share price today, managing director Andrew McLellan said:

Our agreement with FISI will make some contribution to our revenues by way of licence and development fees over the next 18-24 months, but most importantly this agreement provides Bluechiip a solid foothold in a lucrative worldwide market, with a strong international partner.

With more than 2.5 million IVF cycles performed globally each year, the total potential market for a new FISI system incorporating Bluechiip enabled technology is attractive and is expected to result in significant business growth.

About the Bluechiip share price

Over the past 12 months, Bluechiip shares have moved sideways, resulting in a 2% loss for the period. However, its shares have gained around 13% this year to date.

Based on today's price, Bluechiip has a market capitalisation of roughly $29.3 million, with approximately 597.9 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

Happy woman holding white house model in hand and pointing to it with a pen.
Technology Shares

PEXA goes live with NatWest in the UK. Is this the breakthrough investors have been waiting for?

Getting a major bank like NatWest live on the platform shows that PEXA can integrate into the UK system.

Read more »

A man has a surprised and relieved expression on his face.
Technology Shares

ASX 300 stock rockets 38% on 'landmark moment'

It is a day to remember for the company and its shareholders.

Read more »

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Technology Shares

Which ASX battered tech stock has the most upside according to brokers?

Which do brokers prefer?

Read more »

A man thinks very carefully about his money and investments.
Technology Shares

Could this beaten-down ASX 200 stock double in the next 12 months?

WiseTech shares are under pressure as sentiment and rates shift.

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

Why are these 2 defence stocks tumbling today?

Two ASX defence stocks are falling despite no new announcements.

Read more »

Sad child holds paper and leans with head in hand near a computer looking downcast.
Technology Shares

Down another 5% today: Is the party finally over for the EOS share price?

Here's what analysts expect next.

Read more »

Woman in celebratory fist move looking at phone.
Technology Shares

This could be a once-in-a-decade opportunity to buy cheap ASX tech stocks

For long-term investors, this could be a moment worth paying attention to.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Technology Shares

What's going on with DroneShield shares today?

Easing tensions in the Middle East are holding back this defence stock today.

Read more »